NCT05214742View on ClinicalTrials.gov

Developing Derived Induced Pluripotent Stem Cells as a Model to Understand Imprinted Disorders

Enrolling by invitationOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

January 30, 2022

Study Completion Date

December 31, 2026

Conditions
Induced Pluripotent Stem Cells
Interventions
OTHER

Diagnostic Test

Molecular diagnosis carried out in the context of care

Trial Locations (1)

75012

Hôpital Trousseau, Paris

All Listed Sponsors
lead

Institute of Cardiometabolism and Nutrition, France

OTHER